162 related articles for article (PubMed ID: 24408018)
1. The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.
Ryk C; Hou SM; Pershagen G; Wiklund NP; Nyberg F; de Verdier PJ
Tumour Biol; 2014 May; 35(5):4425-34. PubMed ID: 24408018
[TBL] [Abstract][Full Text] [Related]
2. The (CCTTT)n microsatellite polymorphism in the nitric oxide synthase 2 gene may influence bladder cancer pathogenesis.
Ryk C; Steineck G; Wiklund NP; Nyberg T; de Verdier PJ
J Urol; 2010 Nov; 184(5):2150-7. PubMed ID: 20850837
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms In The Nitric-Oxide Synthase 2 Gene And Prostate Cancer Pathogenesis.
Ryk C; de Verdier P; Montgomery E; Peter Wiklund N; Wiklund F; Grönberg H
Redox Biol; 2015 Aug; 5():419. PubMed ID: 28162285
[TBL] [Abstract][Full Text] [Related]
4. The (CCTTT) n pentanucleotide repeat polymorphism in the inducible nitric oxide synthase gene promoter and the risk of psoriasis in Taiwanese.
Chang YC; Wu WM; Huang YH; Chung WH; Tsai HY; Hsu LA
Arch Dermatol Res; 2015 Jul; 307(5):425-32. PubMed ID: 25663087
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration.
Leung TF; Liu EK; Li CY; Chan IH; Yung E; Lam CW; Wong GW
Pediatr Pulmonol; 2006 Jul; 41(7):649-55. PubMed ID: 16703578
[TBL] [Abstract][Full Text] [Related]
6. Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
Ryk C; Koskela LR; Thiel T; Wiklund NP; Steineck G; Schumacher MC; de Verdier PJ
Redox Biol; 2015 Dec; 6():272-277. PubMed ID: 26298202
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase promoter polymorphism in human brucellosis.
Orozco G; Sánchez E; López-Nevot MA; Caballero A; Bravo MJ; Morata P; de Dios Colmenero J; Alonso A; Martín J
Microbes Infect; 2003 Nov; 5(13):1165-9. PubMed ID: 14623011
[TBL] [Abstract][Full Text] [Related]
8. CCTTT pentanucleotide repeats in inducible nitric oxide synthase gene expression in patients with pulmonary arterial hypertension.
Baloira Villar A; Pousada Fernández G; Vilariño Pombo C; Núñez Fernández M; Cifrián Martínez J; Valverde Pérez D
Arch Bronconeumol; 2014 Apr; 50(4):141-5. PubMed ID: 24439467
[TBL] [Abstract][Full Text] [Related]
9. Association Between rs3833912/rs16944 SNPs and Risk for Cerebral Palsy in Mexican Children.
Torres-Merino S; Moreno-Sandoval HN; Thompson-Bonilla MDR; Leon JAO; Gomez-Conde E; Leon-Chavez BA; Martinez-Fong D; Gonzalez-Barrios JA
Mol Neurobiol; 2019 Mar; 56(3):1800-1811. PubMed ID: 29931509
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
[TBL] [Abstract][Full Text] [Related]
11. Association evidence of CCTTT repeat polymorphism in the iNOS promoter and the risk of atrial fibrillation in Taiwanese.
Hsu LA; Yeh YH; Chen WJ; Kuo CT; Tsai FC; Chan YH; Wang CL; Chang CJ; Tsai HY
Sci Rep; 2017 Feb; 7():42388. PubMed ID: 28205526
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
[TBL] [Abstract][Full Text] [Related]
13. The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding.
Motallebipour M; Rada-Iglesias A; Jansson M; Wadelius C
Mol Vis; 2005 Nov; 11():950-7. PubMed ID: 16288199
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease.
Senhaji N; Nadifi S; Zaid Y; Serrano A; Rodriguez DAL; Serbati N; Karkouri M; Badre W; Martín J
World J Gastroenterol; 2017 Dec; 23(47):8300-8307. PubMed ID: 29307990
[TBL] [Abstract][Full Text] [Related]
15. Exhaled nitric oxide and inducible nitric oxide synthase gene polymorphism in Japanese asthmatics.
Sato S; Wang X; Saito J; Fukuhara A; Uematsu M; Suzuki Y; Sato Y; Misa K; Nikaido T; Fukuhara N; Tanino Y; Munakata M
Allergol Int; 2016 Jul; 65(3):300-5. PubMed ID: 27021121
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
[TBL] [Abstract][Full Text] [Related]
17. Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations.
Hirai K; Shirai T; Suzuki M; Shimomura T; Itoh K
J Allergy Clin Immunol; 2018 Aug; 142(2):663-665.e3. PubMed ID: 29518423
[No Abstract] [Full Text] [Related]
18. The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus.
López-Nevot MA; Ramal L; Jiménez-Alonso J; Martín J
Rheumatology (Oxford); 2003 Jan; 42(1):113-6. PubMed ID: 12509623
[TBL] [Abstract][Full Text] [Related]
19. Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis.
Gonzalez-Gay MA; Llorca J; Palomino-Morales R; Gomez-Acebo I; Gonzalez-Juanatey C; Martin J
Clin Exp Rheumatol; 2009; 27(1):116-9. PubMed ID: 19327239
[TBL] [Abstract][Full Text] [Related]
20. No evidence for association of the inducible nitric oxide synthase promoter polymorphism with Trypanosoma cruzi infection.
Calzada JE; López-Nevot MA; Beraún Y; Martín J
Tissue Antigens; 2002 Apr; 59(4):316-9. PubMed ID: 12135432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
